Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
This paper examines the evidence supporting treatments within the renin-angiotensin aldosterone system (RAS), the role cardioprotection plays within the management of hypertension, considerations around medication adherence, and the role of the nurse or nurse practitioner in guiding patients to achi...
Saved in:
Main Author: | Nancy Houston Miller (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2010-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Overview of Regulation of the Renin-Angiotensin-Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010) -
Renin-Angiotensin Aldosterone System
Published: (2021) -
New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
by: Atsuhiro Ichihara, et al.
Published: (2010) -
New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Mineralocorticoid-Receptor Blockers Exert Antihypertensive and Renoprotective Effects Independently of the Renin-Angiotensin System
by: Akira Nishiyama, et al.
Published: (2010) -
Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
by: Ewa Szczepanska-Sadowska, et al.
Published: (2021)